Comparison of the Effect of Remimazolam and Propofol on Perioperative Hypothermia Under Spinal Anesthesia

Sponsor
Wonkwang University Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT05574257
Collaborator
(none)
82
1
2
7
11.7

Study Details

Study Description

Brief Summary

After dividing the patients into two groups, sedation is performed with propofol and remimazolam, respectively, after spinal anesthesia. Compare the patient's body temperature change after surgery.

Detailed Description

Patients in the study were randomly assigned to the propofol group (Group P) and the remimazolam group (Group R) in a 1:1 ratio. Study drugs are prepared in the same 50 ml syringe, double-blind to group assignment. All patients are not given pre-anesthetic medication, and body temperature, blood pressure, and heart rate are measured in the recovery room after surgery at 10-minute intervals from just before anesthesia induction to surgery. If hypotension or bradycardia occurs during surgery and is not corrected even after rapid fluid infusion, ephedrine is increased by 10 mg or glycopyrrolate 0.2 mg or atropine 0.5 mg is administered.

If spinal anesthesia is successfully performed, check the patient's anesthesia height. When the appropriate level of anesthesia is confirmed, Group P receives propofol at 25-100ug/kg/min and maintains the BIS at 70-80. Group R receives remimazolam at 1-20ug/kg/min and maintains BIS between 70-80. Both groups apply a conventionally used air heating device, and the operating room temperature is kept at 20 °C. If shivering occurs during surgery, the elapsed time from induction and the shivering grades are recorded.

At the end of the surgery, record total anesthesia time and surgery time, fluid dose, and drug use. After moving to the recovery room, the patient's body temperature, systolic blood pressure, diastolic pressure, heart rate, the incidence of shivering, and the grade of shivering are checked. When shivering occurs, a forced air-warming device is applied first, and if shivering continues, administer meperidine in 5mg increments until the patient is comfortable and record the total dose.

Study Design

Study Type:
Interventional
Actual Enrollment :
82 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Comparison of the Effect of Remimazolam and Propofol on Perioperative Hypothermia Under Spinal Anesthesia: A Randomized Control Study.
Actual Study Start Date :
Feb 1, 2022
Actual Primary Completion Date :
May 30, 2022
Actual Study Completion Date :
Sep 2, 2022

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Group P

The group received propofol injection at 25-100ug/kg/min (immediately after spinal anesthesia to the end of surgery).

Drug: Propofol
Propofol is injected at 25-100ug/kg/min (immediately after spinal anesthesia to the end of surgery) to maintain the BIS at 70-80.
Other Names:
  • Fresofol®
  • Experimental: Group R

    The group received remimazolam injection at 1-20ug/kg/min (immediately after spinal anesthesia to the end of surgery).

    Drug: Remimazolam
    Remimazolam is injected at 1-20ug/kg/min (immediately after spinal anesthesia to the end of surgery) to maintain the BIS at 70-80.
    Other Names:
  • Byfavo®
  • Outcome Measures

    Primary Outcome Measures

    1. The incidence of perioperartive hypothermia [During surgery]

      Measure the body temperature on the tympanic membrane three times and enter the highest value.

    2. The incidence of perioperartive hypothermia [At PACU (Post Anesthesia Care Unit)]

      measure the body temperature three times on the tympanic membrane and enter the highest value.

    Secondary Outcome Measures

    1. core body temperature [Before the induction of anesthesia]

      Every 10 minutes, measure the body temperature three times on the tympanic membrane and enter the highest value.

    2. core body temperature [During surgery]

      Every 10 minutes, measure the body temperature three times on the tympanic membrane and enter the highest value.

    3. core body temperature [At PACU]

      Every 10 minutes, measure the body temperature three times on the tympanic membrane and enter the highest value.

    4. shivering grades [During surgery]

      None (Grade 0): no shivering noted on palpation of the masseter, neck, or chest wall Mild (Grade 1): shivering localized to the neck and/or thorax only Moderate (Grade 2): shivering involved the gross movement of the upper extremities (in addition to neck and thorax) Severe (Grade 3): shivering involved gross trunk and upper and lower extremities movements.

    5. shivering grades [At PACU]

      None (Grade 0): no shivering noted on palpation of the masseter, neck, or chest wall Mild (Grade 1): shivering localized to the neck and/or thorax only Moderate (Grade 2): shivering involved the gross movement of the upper extremities (in addition to neck and thorax) Severe (Grade 3): shivering involved gross trunk and upper and lower extremities movements.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    19 Years to 65 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Those aged between 19 and under 65 who are undergoing surgery under spinal anesthesia at Wonkwang University Hospital.

    • American Society of Anesthesiologists' physical status class (ASA) award class I-III.

    Exclusion Criteria:
    • Patients with fever before surgery

    • Patients taking antipyretics before surgery

    • Patients who are chronically using anti-inflammatory drugs

    • High-risk patients with ASA class IV or higher

    • Patient who refused sedation

    • Patients with thyroid dysfunction.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Wonkwag UH Iksan Jeollabukdo Korea, Republic of 54538

    Sponsors and Collaborators

    • Wonkwang University Hospital

    Investigators

    • Principal Investigator: Cheolhyeong Lee, M.D., Wonkwang University Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Cheol Lee,MD,PhD,, Professor of Anesthesiology and Pain Medicine, Wonkwang University Hospital
    ClinicalTrials.gov Identifier:
    NCT05574257
    Other Study ID Numbers:
    • WonkwangUH12
    First Posted:
    Oct 10, 2022
    Last Update Posted:
    Oct 10, 2022
    Last Verified:
    Oct 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Oct 10, 2022